Society
Personalised mRNA Vaccine Cuts Melanoma Death Risk
Groundbreaking mRNA vaccine intismeran reduces melanoma recurrence risk by targeting individual genetic mutations. Phase III trial shows personalised cancer tre...
Groundbreaking mRNA vaccine intismeran reduces melanoma recurrence risk by targeting individual genetic mutations. Phase III trial shows personalised cancer tre...